Jakafi 15 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZJ6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,583
Award facts
- Contract value 100% obligated
- $12,582.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,582.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on January 28, 2026, for the supply of Jakafi 15 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for ultimate completion by January 29, 2026, with performance taking place at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999. The broader PPV-G GEN V acquisition strategy represents a $30.3 billion federal pharmaceutical supply initiative designed to support recurring medical supply needs of military healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, vaccines, and medical consumables to Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCZJ6?
SPE2DR26FCZJ6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FCZJ6 worth?
The government has obligated $12,583 on SPE2DR26FCZJ6.
Is contract SPE2DR26FCZJ6 an order under another contract?
Yes. SPE2DR26FCZJ6 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZJ6 competed?
The extent of competition for SPE2DR26FCZJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award